Ian S. Mitchell,James F. Blake,Rui Xu,Nicholas C. Kallan,Dengming Xiao,Keith Lee Spencer,Josef R. Bencsik,Eli M. Wallace,Stephen T. Schlacter,Anna L. Banka,Jun Liang,Brian Safina,Jun Li,Christine Chab
申请号：
US14456670
公开号：
US20140349996A1
申请日:
2014.08.11
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
